| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-203 | |
| Phytochemical name or plant extracts | Coryllus avellana extract | |
| PMID | 28258038 | |
| Literature evidence | The increasing rate of cancer incidence has encouraged the search for novel natural sources of anticancer compounds. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Methanolic extract | |
| Source of phytochemicals or plant Extracts | Corylus avellana | |
| Geographical availability | Albania, Austria, Baltic States, Belarus, Belgium, Bulgaria, Central European Rus, Corse, Czechoslovakia, Denmark, East Aegean Is., East European Russia, Finland, France, Føroyar, Germany, Great Britain, Greece, Hungary, Ireland, Italy, Krym, Netherlands, North Caucasus, North European Russi, Northwest European R, Norway, Poland, Portugal, Romania, Sardegna, Sicilia, South European Russi, Spain, Sweden, Switzerland, Transcaucasus, Turkey, Ukraine, Yugoslavia | |
| Plant parts | Leaves and stem | |
| Other cancers | Breast cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | Our results suggest a potential use of C. avellana extracts in the pharmacotherapy of cervical cancer and hepatocarcinoma and, to a lesser extent, breast cancer. | |
| Cell line/ mice model | HeLa, HepG2 and MCF-7 | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:295446-1 | |
| Safety | NA |